Dr.Reddys Laboratories reported 9B in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aspen Pharmacare APN:SJ 4.8B 902M
Bharat Petroleum BPCL:IN 43.51B 5.55B
Cipla CIPLA:IN 4.59B 5.24B
Dr.Reddys Laboratories DRRD:IN 9B 263M
Reliance Infra RELI:IN 233.65B 13.42B
Sun Pharmaceuticals SUNP:IN 16.23B 4.4B
UPL UPLL:IN 29.5B 8.85B